Excretion of 3-methoxy-4-hydroxymandelic acid and 5-hydroxyindoleacetic acid in depressed patients treated with imipramine
- 1 September 1967
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 5 (3) , 213-220
- https://doi.org/10.1016/0022-3956(67)90003-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Prolonged Decrease in Vanilmandelic (3-Methoxy-4-Hydroxy-mandelic) Acid Excretion by Man during and after Nialamide TreatmentActa Pharmacologica et Toxicologica, 2009
- Catecholamine metabolism in affective disorders: I.Journal of Psychiatric Research, 1965
- Release of 5-hydroxytryptamine from blood plateletsJournal of Pharmacy and Pharmacology, 1965
- Role played by catechol and indolamines in the central actions of reserpine after monoaminoxidase inhibitionInternational Journal of Neuropharmacology, 1965
- Reserpine and cocaine blocking of the uptake and storage mechanisms in adrenergic nervesLife Sciences, 1964
- Niamid parentéral à hautes doses dans les syndromes dépressifsEuropean Neurology, 1964
- SOME ANTIDEPRESSANT DRUGS AND THEIR MECHANISM OF ACTION ON EXCITABLE MEMBRANES *Annals of the New York Academy of Sciences, 1963
- THE EFFECT OF IMIPRAMINE ON THE 5-HYDROXYTRYPTAMINE CONTENT AND MONO-AMINE OXIDASE ACTIVITY OF THE RAT BRAIN AND ON THE EXCRETION OF 5-HYDROXYINDOLE ACETIC ACIDJournal of Neurochemistry, 1961
- Versuche mit Marsilid und Marsilid-AnalogenEuropean Neurology, 1960
- Effect of Marsilid on Excretion of 3-Methoxy-4-Hydroxymandelic Acid in ManScandinavian Journal of Clinical and Laboratory Investigation, 1959